Wu Jun, Chen Ming-fa, Xia You-chen, Guo Yan, Lin Yong, Sun Chan, Zhang Chun-yan, Chen Yan, Liu Shen-pei, Hao You-hua, Lu Meng-ji, Schlaak Jörg F, Yang Dong-liang
Division of Clinical Immunology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Zhonghua Gan Zang Bing Za Zhi. 2011 Nov;19(11):838-42. doi: 10.3760/cma.j.issn.1007-3418.2011.11.011.
This report aims to investigate the Toll-like receptor (TLR) signaling pathways and induced antiviral activity in hepatocytes.
We isolated primary hepatocytes from wild-type C57BL/6 mice and examined the expression of TLR by realtime RT-PCR. Hepatocytes were stimulated with TLR 1-9 agonists and the supernatants were harvested. The secretion of cytokines were tested by ELISA. The antiviral effectors in supernatants were assayed via virus protection assay (in EMCV system) and the control of HBV replication were assessed via Southern blotting (in HBV system).
We demonstrated that hepatocytes expressed TLR1-9. In accordance with these TLR expression profiles, hepatocytes responded to all TLR ligands by producing inflammatory cytokines (TNF-α or IL-6), to TLR -1,-3,-7 and -9 ligands by producing type I IFN (IFN-α or IFN-β). Only TLR 3 and TLR 7 agonists could stimulate the production of high amounts of antiviral mediators by hepatocytes in virus protection assay. By contrast, supernatants from TLR1, -3 and -4 directly stimulated hepatocytes and TLR 3, -7 and -9 transfected hepatocytes were able to potently suppress HBV replication.
Primary hepatocytes display a unique TLR signaling pathway and can control HBV replication after stimulation by TLR agonists in mice. It may be helpful for the development of TLR-based therapeutic approaches against hepatotropic virus.
本报告旨在研究Toll样受体(TLR)信号通路及肝细胞中诱导的抗病毒活性。
我们从野生型C57BL/6小鼠中分离出原代肝细胞,通过实时RT-PCR检测TLR的表达。用TLR 1-9激动剂刺激肝细胞并收集上清液。通过ELISA检测细胞因子的分泌。通过病毒保护试验(在脑心肌炎病毒系统中)测定上清液中的抗病毒效应物,并通过Southern印迹法(在乙肝病毒系统中)评估乙肝病毒复制的控制情况。
我们证明肝细胞表达TLR1-9。根据这些TLR表达谱,肝细胞通过产生炎性细胞因子(TNF-α或IL-6)对所有TLR配体作出反应,通过产生I型干扰素(IFN-α或IFN-β)对TLR -1、-3、-7和-9配体作出反应。在病毒保护试验中,只有TLR 3和TLR 7激动剂能刺激肝细胞产生大量抗病毒介质。相比之下,来自TLR1、-3和-4直接刺激的肝细胞以及TLR 3、-7和-9转染的肝细胞的上清液能够有效抑制乙肝病毒复制。
原代肝细胞显示出独特的TLR信号通路,在小鼠中经TLR激动剂刺激后可控制乙肝病毒复制。这可能有助于开发基于TLR的抗嗜肝病毒治疗方法。